Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: An analysis from a regional healthcare network-Reference-Cited by-同舟云学术

Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: An analysis from a regional healthcare network

Published:2014-10-20 Issue:12 Volume:89 Page:E244-E252
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Bories Pierre¹²,Bertoli Sarah¹,Bérard Emilie³⁴,Laurent Julie³,Duchayne Eliane⁵,Sarry Audrey¹,Delabesse Eric⁵⁶,Beyne-Rauzy Odile¹⁶,Huguet Françoise¹,Récher Christian¹⁶

Affiliation:

1. Département d'Hématologie-Médecine Interne; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse Oncopole; Toulouse France

2. Service d'Hématologie; Hôpitaux Universitaires de Strasbourg; F-67098 Strasbourg France

3. Service d'Epidémiologie; Centre Hospitalier Universitaire de Toulouse; Toulouse France

4. UMR 1027; INSERM-Université de Toulouse III; Toulouse France

5. Laboratoire d'Hématologie; Centre Hospitalier Universitaire de Toulouse; Hôpital Purpan Toulouse France

6. Université Toulouse III Paul Sabatier; Toulouse France

Funder

National Research Agency (ANR) and French government under the “Investissement d'avenir” Program

Publisher

Wiley

Subject

Hematology

Reference32 articles.

1. Age and acute myeloid leukemia;Appelbaum;Blood,2006

2. Therapeutic advances in acute myeloid leukemia;Burnett;J Clin Oncol,2011

3. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: The results of the United Kingdom Medical Research Council AML11 trial;Goldstone;Blood,2001

4. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment;Burnett;Cancer,2007

5. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study;Leukemia Research;2024-01

2. Improving long-term outcomes with intensive induction chemotherapy for patients with AML;Hematology;2023-12-08

3. Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review;PLOS ONE;2022-12-05

4. Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making;Oncology and Therapy;2022-06-13

5. Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study;Leukemia & Lymphoma;2022-01-04